DEPAKOTE CP
LOE ApproachingNDAORALTABLET, DELAYED RELEASE
Approved
Jul 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 23h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DEPAKOTE CP is a delayed-release oral tablet formulation of divalproex sodium, a small-molecule anticonvulsant approved in 1990. The mechanism of action involves enhancing GABA neurotransmission and stabilizing neuronal membranes. It is indicated for epilepsy, bipolar disorder, and migraine prophylaxis across multiple patient populations.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating declining team investment and potential restructuring opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on DEPAKOTE CP offers limited growth opportunity as the product approaches LOE, but represents a stable, legacy brand with deep market presence and established customer relationships. Career progression may be constrained by product lifecycle stage, with emphasis shifting to defensive strategies and cost optimization.
Brand ManagerField Sales Representative
Worked on DEPAKOTE CP at Abbott? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.